What patent covers Prostascint, and what is it for?
Prostascint is a prostate cancer imaging agent (an antibody-based scan used for staging/restaging). The “Prostascint patent” usually refers to one or more patents covering the antibody/labeling technology and the method of using that labeled antibody for imaging.
How can I find the exact Prostascint patent number?
To identify the correct patent, you typically need one of these:
- The applicant/assignee listed on the product or original approval filings
- The brand’s generic/active ingredient naming used in patents (the labeled antibody used for imaging)
- The country (US vs. EP/WO) and the specific claim type you care about (composition vs. method vs. process)
With only the product name provided, there isn’t enough information to reliably name the specific patent number(s) without risking a wrong citation.
If you share either (a) the manufacturer/assignee name you’re looking at, (b) the country (US/EU), or (c) the patent number you saw mentioned, I can help you pinpoint the exact patent and summarize what it covers.
When does a Prostascint patent expire (and when could generics/biosimilars enter)?
Patent expiry depends on:
- The specific patent (primary vs. formulation/process vs. method-of-use)
- Filing date and jurisdiction
- Any extensions (where applicable) and whether exclusivity is driven by patents vs. regulatory data exclusivity
Because Prostascint is an imaging antibody product, exclusivity and market entry timing may involve patent cliffs plus regulatory exclusivity, not just a single “expiration date.”
Are there related patents, continuations, or lawsuits that affect timing?
It’s common for branded biologic/imaging antibody products to have multiple overlapping patent families (original filings plus later “continuation” patents). Those can delay entry even if one patent nears expiry.
If you tell me the jurisdiction (e.g., “US”) and what you’re trying to determine (expiry date, litigation risk, or freedom-to-operate), I can narrow to the relevant patent set and explain what matters most.
What do people usually mean when they search “Prostascint patent”?
Common follow-up goals include:
- “What is the patent that blocks a competitor?”
- “Has the patent expired yet?”
- “Could a competing labeled antibody imaging agent enter?”
- “What patents cover the labeled antibody vs. the imaging method?”
Reply with the specific context (expiry check, competition, or a patent number you found) and the jurisdiction, and I’ll tailor the answer to that exact “Prostascint patent” question.